Physician profile
Elnora King
NPI 1063067577
$2,783.71
in general payments reported to CMS, 2019-2025
16 companies · $256 in 2025
The $256 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $266 · 2022: $401 · 2023: $827 · 2024: $1,033 · 2025: $256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,116.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $640.11 | 2023-2025 | Austedo Xr, Uzedy, Austedo Xr |
| Neurocrine Biosciences, INC. | $508.04 | 2021-2025 | Ingrezza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $427.22 | 2021-2024 | Jardiance |
| Abbvie INC. | $137.81 | 2022-2025 | |
| Novo Nordisk INC | $124.38 | 2022 | |
| Nevro Corp. | $120.89 | 2022-2024 | Senza |
| Axsome Therapeutics, INC. | $120.44 | 2024 | Sunosi |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $115.05 | 2024-2025 | Caplyta |
| Jazz Pharmaceuticals INC. | $111.49 | 2021 | |
| Gilead Sciences, INC. | $109.37 | 2023-2024 | Trodelvy |
| Vanda Pharmaceuticals INC. | $105.51 | 2024 | Fanapt |
| Janssen Pharmaceuticals, INC | $80.43 | 2023-2025 | Invega Sustenna, Invega Trinza |
| Otsuka America Pharmaceutical, INC. | $73.10 | 2024 | Rexulti |
| Corium, LLC | $63.20 | 2023 | Azstarys |
| Avanir Pharmaceuticals, INC. | $28.48 | 2021-2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $18.19 | 2025 | Aristada, Lybalvi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elnora King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.